Shenyang Xingqi Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥18.16 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	26.73
Forward PE	16.23
Price to Sales TTM	CN¥7.19
Price to Book MRQ	CN¥9.29
Enterprise to Revenue	7.06
Enterprise to EBITDA	19.59

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	26.84%
Operating Margin	44.65%
Return on Assets TTM	20.85%
Return on Equity TTM	37.08%

Income Statement

Revenue TTM	CN¥2,407,823,872
Revenue per Share TTM	CN¥9.84
Quarterly Revenue Growth	35.30%
Gross Profit TTM	CN¥1,938,959,872
EBITDA	CN¥598,238,298
Net Income to Common TTM	CN¥646,205,312
Diluted EPS TTM	CN¥2.63
Quarterly Earnings Growth YoY	117.50%

Balance Sheet

Total Cash MRQ	CN¥379,512,288
Total Cash per Share MRQ	CN¥1.55
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	7.21
Current Ratio MRQ	1.90
Book Value per Share MRQ	CN¥7.57

Cash Flow

Operating Cash Flow TTM	CN¥635,837,376
Levered Free Cash Flow TTM	CN¥374,183,168

300573 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	245,348,945
Float Shares	170,198,563
Avg 10 Volume	4,623,499
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	32.28%
% Held by Institutions	5.68%

Stock Price Summary

Beta	0.41
Fifty Two Week Low	CN¥46.45
Fifty Two Week High	CN¥85.65
Fifty Two Week Change	31.04%
Day 50 MA	CN¥72.56
Day 200 MA	CN¥62.96

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.40
Forward Annual Dividend Yield	1.99%
Trailing Annual Dividend Rate	CN¥1.41
Trailing Annual Dividend Yield	2.01%
Payout Ratio	67.38%
Dividend Date
Ex Dividend Date	2025-09-24
Last Split Factor
Last Split Date	2025-05-22